Correlation Between Intellia Therapeutics and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Intellia Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Pliant Therapeutics.
Diversification Opportunities for Intellia Therapeutics and Pliant Therapeutics
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Intellia and Pliant is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Pliant Therapeutics
Given the investment horizon of 90 days Intellia Therapeutics is expected to generate 0.78 times more return on investment than Pliant Therapeutics. However, Intellia Therapeutics is 1.28 times less risky than Pliant Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 3,496 in Intellia Therapeutics on November 28, 2024 and sell it today you would lose (2,401) from holding Intellia Therapeutics or give up 68.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Pliant Therapeutics
Performance |
| Timeline |
| Intellia Therapeutics |
| Pliant Therapeutics |
Intellia Therapeutics and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Pliant Therapeutics
The main advantage of trading using opposite Intellia Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |